Please note: This review reflects information we gathered on the date it was researched and may now be out of date. Providers frequently change their pricing, plans, medications, and policies. Any ratings, reviews, and customer feedback are gathered from publicly available online sources and may have since changed or no longer be accurate. Always do your own research and confirm the latest details directly with the provider before making any decision.
Amazon One Medical Review
The most consequential thing to happen to GLP-1 pricing in a while: FDA-approved Wegovy, Zepbound and Foundayo from $149/month cash, $25 with insurance, and $50 for eligible Medicare members. Brand-name medication at prices that finally compete with compounded.
Amazon One Medical
Brand-Name, No CompoundingAmazon's GLP-1 Management Program combines One Medical primary care, virtual visits and Amazon Pharmacy fulfilment into one route to weight-management medication. It is aimed at people who want an FDA-approved drug rather than a compounded copy, and who have been priced out of that until now. It covers all 50 states, and One Medical membership is not required to start.
The headline is the pricing, because it changes the standard advice. Amazon lists the Wegovy oral pill and Foundayo from $149/month cash, Wegovy injectable and the Zepbound auto-injector and KwikPen from $299/month, insurance pricing from $25/month on the orals, and — for eligible Medicare Part D members meeting clinical criteria — $50/month under the Medicare GLP-1 Bridge Program. Until recently, brand-name GLP-1s without insurance routinely meant four-figure monthly bills.
Everything here is FDA-approved. There is no compounded product anywhere in the programme — which means none of the questions that dominate the rest of this site apply: no unapproved preparations, no pharmacy sourcing to interrogate, no marketing that describes a compounded copy as equivalent to the branded drug. Manufacturer savings cards from Novo Nordisk and Eli Lilly are applied automatically at checkout, free home delivery reaches all 50 states, and same-day delivery covers around 3,000 cities.
The honest caveats: $299 for injectables is still meaningfully more than a $99 compounded plan, the $50 Medicare price is scheduled to run only to the end of 2027, and new prescriptions require a One Medical clinician rather than a provider of your choosing. Prescribing here also involves a real clinical assessment, so it will not approve everyone.
Disclosure — we earn nothing from this one: GLP1Drugs.org has no affiliate relationship with Amazon, and we receive no commission if you use this programme. We are recommending it anyway, because for a lot of readers it is now the best available option. It also means we could not test the purchase flow end to end, so the detail here comes from Amazon's own published announcements, checked on 7 August 2026.
Read Amazon's Programme DetailsOur Top Recommended Provider: CoreAge Rx
After reviewing dozens of GLP-1 telehealth providers, CoreAge Rx is the one we recommend most. CoreAge Rx is one of our partners — read on for why we recommend them:
Flat-Rate Pricing
Same cost at every dose level — no price jumps as you titrate up.
Verified Pharmacies
US-licensed physicians and NABP-verified 503A compounding pharmacies you can trust.
Everything Included
Medication, supplies, free shipping, and ongoing clinical support — no hidden fees.
Active Community of Members
Ask questions, share progress, and get answers from other patients on the same journey — alongside ongoing clinical support from your care team.
$25
Oral, With Insurance
$50
Eligible Medicare*
$149
Oral, Cash Pay
$299
Injectable, Cash Pay
*Medicare GLP-1 Bridge Program, for eligible Part D members meeting clinical criteria, running through 31 December 2027. All medications FDA-approved. Per month.
Every Route, Priced
From Amazon's own published figures, checked 7 August 2026.
| Medication | Form | Cash | With insurance | FDA-Approved |
|---|---|---|---|---|
| Wegovy oral pill | Daily tablet | From $149/mo | From $25/mo | Yes |
| Foundayo (orforglipron) | Daily tablet | From $149/mo | From $25/mo | Yes |
| Wegovy injectable | Weekly injection | From $299/mo | Plan-dependent | Yes |
| Zepbound / KwikPen | Weekly injection | From $299/mo | Plan-dependent | Yes |
| Medicare Bridge Program | Wegovy (both forms), Zepbound KwikPen, Foundayo | $50/mo | Part D, to 31 Dec 2027 | Yes |
Compare that against the compounded market. The cheapest verified compounded semaglutide we have found is $69/month, and the typical credible range is $99–$159 — for a product that is not FDA-approved. At $149 for an approved oral GLP-1, and $25 with insurance, the calculation that pushed most people toward compounding no longer holds the way it did. The injectable premium is real, but it is a premium over an unapproved alternative, not over an equivalent one.
What's Included
FDA-Approved Medication Only
Wegovy, Zepbound, the Zepbound KwikPen and Foundayo — all approved products. Nothing on this platform is compounded
Oral GLP-1 Options
The Wegovy oral pill and Foundayo (orforglipron), from $149/month cash — needle-free and genuinely approved, not a compounded 'oral drop'
Injectables
Wegovy injectable and the Zepbound auto-injector and KwikPen, from $299/month cash
Integrated Primary Care
One Medical clinicians handle pre-visit screening, consultations, follow-ups and monitoring, with what Amazon describes as evidence-based treatment algorithms and built-in safety protocols
Same-Day Delivery
Free home delivery nationwide, with same-day delivery in roughly 3,000–3,100 cities, expanding toward 4,500 by the end of 2026
Automatic Savings Cards
Novo Nordisk and Eli Lilly manufacturer savings cards are applied automatically at checkout for eligible patients — no codes, no forms, no phone calls
Pros & Cons
Pros
- ✓Everything it dispenses is FDA-approved brand-name medication — no compounded products anywhere in the programme
- ✓Cash pricing from $149/month for oral GLP-1s materially undercuts what brand-name has historically cost, and competes with compounded platforms
- ✓Insurance pricing from $25/month for the oral medications, and Amazon accepts most major insurance plans
- ✓Eligible Medicare Part D members can get Wegovy, the Zepbound KwikPen or Foundayo for $50/month under the Medicare GLP-1 Bridge Program
- ✓One Medical membership is not required to start or to book a visit
- ✓Manufacturer savings cards are applied automatically at checkout rather than requiring you to chase them
- ✓Prescribing sits inside a primary care relationship rather than a two-minute intake form
- ✓Same-day delivery in around 3,000 cities, free home delivery to all 50 states, and 24/7 access to licensed pharmacists
- ✓Existing prescription holders can use 24/7 on-demand renewal appointments
Cons
- ✕$299/month for injectables is still well above compounded platforms charging $99–$159
- ✕The $50 Medicare Bridge Program price runs only through 31 December 2027 and requires meeting specific clinical criteria
- ✕You need a One Medical clinician for a new prescription, so this is not a pick-your-own-provider marketplace
- ✕Copays and deductibles still apply when visits are billed to insurance
- ✕Clinical eligibility is assessed properly, which means some people who would be approved by a lax telehealth platform will not be approved here
- ✕Handing an integrated view of your prescriptions, primary care and purchase history to a single company will not suit everyone
- ✕We hold no affiliate relationship with Amazon and earn nothing if you use it — which also means we could not test the purchase flow end to end
How It Works
Book Without a Membership
One Medical membership is not required to get started or schedule a visit. Amazon accepts most major insurance for these appointments, or you can pay cash.
Screening and Consultation
The programme includes pre-visit screening and a consultation with a One Medical clinician, who assesses whether a GLP-1 is clinically appropriate for you.
Prescription to Your Chosen Pharmacy
One Medical clinicians send prescriptions to the pharmacy you choose. Amazon Pharmacy is an option, not an obligation.
Automatic Savings Applied
If you use Amazon Pharmacy, eligible Novo Nordisk and Eli Lilly savings cards are applied at checkout automatically.
Delivery and Follow-Up
Free home delivery nationwide, same-day in around 3,000 cities. Renewals run through your primary care clinician, or via 24/7 on-demand appointments if you already hold a prescription.
How It Compares
Against the routes most people actually weigh. Figures are as recorded in our reviews of each.
| Route | Medication | Cash price | Our rating |
|---|---|---|---|
| Amazon One Medical | FDA-approved brand only | $149 oral / $299 injectable | 4.7 |
| Shed | Compounded, plus Foundayo, Wegovy, Zepbound | $159 compounded | 4.3 |
| Trimi Health | Compounded only | $99 sema / $125 tirz | 4.6 |
| Embody | Compounded only | $69 on annual prepay | 3.0 |
The cheapest row on that table is also the worst-rated, which is the pattern across this whole category. Amazon is the first entrant that lets you step off it: an approved product, at a price a cash-pay patient can plausibly meet, from an operator with no regulatory findings against its GLP-1 programme. If you are currently on a compounded plan largely because brand-name felt out of reach, this is worth pricing before your next refill. See our brand versus compounded guide for why the distinction matters.
Who Is It Best For?
Great Fit
- ✓Anyone who wants FDA-approved medication rather than a compounded copy
- ✓Eligible Medicare Part D members — $50/month is far below any other route we have found
- ✓People with insurance, where oral pricing starts at $25/month
- ✓Needle-averse patients who want an approved oral option rather than compounded drops
- ✓Anyone who wants prescribing inside a primary care relationship rather than a two-minute form
Look Elsewhere If
- —You need an injectable and the absolute lowest cash price — $299 is well above compounded
- —You want to choose your own clinician rather than see a One Medical provider
- —You want compounded tirzepatide specifically, which is not offered here
- —You would rather not consolidate prescriptions, primary care and shopping with one company
- —You do not meet clinical criteria — this programme assesses properly rather than approving everyone
Our Verdict
4.7 / 5 — the first mainstream route to FDA-approved GLP-1 medication at a price that competes with compounded platforms, with insurance pricing from $25 and $50/month for eligible Medicare members. Marked down only for the $299 injectable cash price and the 2027 expiry on the Medicare programme.
Most of this site is about navigating a compounded GLP-1 market full of unapproved products, misleading marketing and providers with FDA warning letters. Amazon's programme sidesteps that entirely. Everything it dispenses is an approved branded medication — Wegovy, Zepbound, Foundayo — made by Novo Nordisk or Eli Lilly, backed by the trials that produced the figures everyone quotes. There is no compounding pharmacy to interrogate and no equivalence claim to scrutinise.
What makes it genuinely significant is that the price is now reachable. $149/month cash for an approved oral GLP-1 sits inside the range compounded platforms charge for unapproved products; $25 with insurance and $50 for eligible Medicare members undercuts everything. Add automatic manufacturer savings cards, no membership requirement, free nationwide delivery with same-day service in around 3,000 cities, and prescribing inside an actual primary care relationship, and the case is strong.
It is not perfect. $299 for injectables remains a real premium over a $99 compounded plan, and if that gap is decisive for your budget then the honest answer is that cheaper routes exist — with the trade-offs we document across this site. The Medicare price expires at the end of 2027. And a One Medical clinician, not one of your choosing, holds the prescribing pen. We earn nothing from recommending this, which is worth saying plainly: we are pointing you at it because for a lot of readers it is now simply the better buy.
Read Amazon's Programme DetailsFrequently Asked Questions
Is this actually cheaper than a compounded GLP-1?
For the oral medications, it is competitive — and that is genuinely new. Amazon lists the Wegovy oral pill and Foundayo from $149/month cash, against compounded semaglutide from the providers we price at roughly $99–$159/month. You are paying about the same, or slightly more, for an FDA-approved product instead of an unapproved compounded one. That is a straightforwardly better deal for most people. For injectables the gap is wider: $299/month cash for Wegovy or the Zepbound KwikPen against $99–$159 compounded. Whether that premium is worth it depends on how much you value approval, standardised dosing and manufacturer-backed supply — but it is a real premium, and we are not going to pretend otherwise.
What about with insurance or Medicare?
This is where it becomes hard to beat. Amazon lists insurance pricing from $25/month for the oral medications and accepts most major insurance plans for its visits. Separately, eligible Medicare Part D members who meet specific clinical criteria can obtain Wegovy — injectable or oral pill — the Zepbound KwikPen or Foundayo for $50/month with free home delivery, under the Medicare GLP-1 Bridge Program, which runs through 31 December 2027. Medicare coverage of weight-management GLP-1s has historically been extremely limited, so a defined $50/month route for eligible members is significant. Note the end date: this is a programme with a scheduled expiry, not a permanent price.
Is any of it compounded?
No, and that is the single most important thing about this programme. Everything listed — Wegovy, Zepbound, the Zepbound KwikPen and Foundayo — is an FDA-approved branded medication. It has been through the review process for safety, effectiveness and manufacturing quality, it is the product the clinical trials actually studied, and it is manufactured by Novo Nordisk or Eli Lilly rather than compounded by a pharmacy. Roughly a dozen providers reviewed on this site have received FDA warning letters for blurring exactly this distinction. Here there is nothing to blur.
What is Foundayo, and why does it matter?
Foundayo is Eli Lilly's brand name for orforglipron, a small-molecule, non-peptide GLP-1 receptor agonist taken as a once-daily tablet, which the FDA approved for chronic weight management on 1 April 2026. Unlike the older oral semaglutide product it can be taken at any time of day without food or water restrictions. In the ATTAIN-1 trial, participants on the highest dose who remained on treatment lost an average of 12.4% of body weight against 0.9% on placebo. It matters here because it gives needle-averse patients a genuinely approved oral option — as opposed to the compounded 'oral drops' and lozenges sold elsewhere, which have no published bioavailability data behind them.
Do I have to become a One Medical member?
No. Amazon states plainly that One Medical membership is not required to get started or to schedule a visit. You do need a One Medical clinician to issue a new prescription, so this is not a marketplace where you pick any provider you like — but there is no membership paywall in front of the programme. If you already hold a GLP-1 prescription, there are 24/7 on-demand cash-pay renewal appointments.
Where can I get it delivered?
All medications reach all 50 states with free home delivery. Same-day delivery covers roughly 3,000 to 3,100 US cities and towns at the time of writing, with Amazon saying it will expand to nearly 4,500 by the end of 2026. There is also in-office pickup at Amazon Pharmacy kiosks in selected One Medical locations, and 24/7 access to licensed pharmacists. For a category where cold-chain shipping delays are a routine complaint, same-day delivery in a metro area is a real operational advantage.
What are the downsides?
Three worth weighing. The injectable cash price of $299/month is genuinely higher than compounded alternatives, so if budget is the binding constraint and you have no insurance, cheaper routes exist — with the trade-offs we describe elsewhere on this site. The $50 Medicare price is time-limited to the end of 2027. And this concentrates your prescriptions, primary care records and purchase history with one company; whether that bothers you is a personal call rather than a clinical one, but it is a reasonable thing to think about before switching your care.
Who should not use these medications?
GLP-1 receptor agonists are contraindicated in anyone with a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2, and in anyone who has had a serious allergic reaction to the medication. They should not be used in pregnancy, while trying to conceive, or while breastfeeding. Common side effects are nausea, vomiting, diarrhoea and constipation, usually worst during dose escalation; more serious risks include pancreatitis, gallbladder disease and kidney injury. Discuss any history of pancreatitis, gallbladder disease, diabetic retinopathy or kidney impairment with the clinician. This page is information, not medical advice.
Compare Other GLP-1 Providers
See how other telehealth providers stack up.
LifeMD
Top RatedPublicly traded telehealth company with comprehensive health platform and competitive pricing
Read Review →Noom
Established PlatformPsychology-based behavior change program combined with GLP-1 medication and coaching
Read Review →Mochi Health
Obesity Medicine SpecialistsBoard-certified obesity medicine specialists with both brand-name and compounded GLP-1 options
Read Review →BeyondMD
Top RatedBoard-certified physician-led care with comprehensive medical oversight
Read Review →JumpstartMD
Comprehensive ProgramMedically supervised program with obesity medicine physicians, dietitians, and in-person options
Read Review →GoodRx Care
Trusted BrandTelehealth platform from GoodRx with transparent pricing and established trust
Read Review →Medical Disclaimer: This page is for informational purposes only and does not constitute medical advice. Always consult a licensed healthcare provider before starting or changing any treatment. GLP-1 medications commonly cause nausea, vomiting, diarrhoea and constipation, and carry risks including pancreatitis, gallbladder disease and kidney injury; they are contraindicated in people with a personal or family history of medullary thyroid carcinoma or MEN 2, and should not be used in pregnancy, when trying to conceive, or while breastfeeding. Prescribing is subject to clinician approval and is not guaranteed. Individual results vary and no outcome is promised.
Sourcing Note: Pricing, medication availability, delivery coverage and programme terms were taken from Amazon's own published announcements and checked on 7 August 2026; they may change. The $50 Medicare price applies to eligible Medicare Part D members meeting specific clinical criteria under the Medicare GLP-1 Bridge Program, which runs through 31 December 2027. Copays and deductibles may apply where visits are billed to insurance. Confirm current pricing and your own eligibility directly with Amazon before relying on any figure here. Because we hold no affiliate relationship with Amazon, we were not able to test the purchase flow end to end.
Affiliate Disclosure: GLP1Drugs.org has no affiliate relationship with Amazon and receives no compensation if you use this programme. Other providers reviewed on this site are affiliate partners; that is disclosed on each of their pages and does not influence our ratings.